Dr. Lin Huanxin, male, was born in November 1965 in Lufeng, Guangdong Province. In 1988, he graduated from Norman Bethune University of Medical Science and ever since he has worked in Radiation Oncology of Sun Yat-sen University Cancer Center. He studied in Paris, France from March 1998 to November 2000. In 2013 he was employed as the chief physician of Sun Yat-sen University. Concurrently he is a member of Committee of Breast Cancer Society of Guangdong Provincial Anticancer Association and a member of Medical Quality and Safety Management Committee of Sun Yat-sen University Cancer Center. He also serves as the Director of Health Care Department for Staff in Sun Yat-sen University Cancer Center.

As an Attending professor of abdominal and thoracic tumor radiotherapy, he mainly focuses on researching breast cancer radiotherapy and clinical transformation. He presided over one general program of National Natural Science Foundation of China, one program of Guangdong Provincial Department of Science and Technology and one project sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars of Sun Yat-sen University Cancer Center all as the first leader. He has published 15 academic papers (> 100 points), including 9 SCI papers, as the lead author or corresponding author. He participated in compilation of the book Diagnosis and Treatment of Nasopharyngeal Carcinoma and was member of editorial board for several other monographs, such as Practical Clinical Radiation Oncology, Handbook of Common Malignant Tumor Radiotherapy and Handbook of Cancer Prevention.

Last Updated on: August 2014 Breast cancer radiotherapy 09/1983-06/1988 Norman Bethune University of Medical Science03/1998-11/2000 Department of Radiation Oncology, Henri Mondor Affiliated Hospital of the No. 12 University of Paris (Université de Paris 12 Val de Marne) and Department of Radiation Oncology, Denon Affiliated Hospital of the No.6 University of Paris [Université Pierre et Marie Curie (Paris VI)]

1. Zeng ZL, Lin HX (Co-first authors), Zhao X, Liu G, Wang X, Xu RH, Chen K, Li J, Song L. Overexpression of GOLPH3 promotes proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor. Clin Cancer Res. 2012;18(15):4059-69. (IF 7.837)2. Lin HX(First author), Dai T, Xiong HP, Zhao XH, Chen XT, Yu CP, Li J, Wang X, Song LB. Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a. Plos One. 2010;5(12):1-10. (IF 3.73)3. Lin HX(First author), Qiu HJ, Zeng F, Rao HL, Yang GF, Kung HF, Zhu XF, Zeng YX, Cai MY, Xie D. Decreased expression of Beclin 1 correlates closely with Bcl-xL expression and poor prognosis of ovarian carcinoma. PLoS One. 2013;8(4):e60516. doi: 10.1371/journal.pone.0060516. Epub 2013 Apr 3. (IF 3.73)4. Wang X, Yang Q, Guo L, Li XH, Zhao XH, Song LB, Lin HX (Co-first authors). Flotillin-2 is associated with breast cancer progression and poor survival outcomes.J Transl Med. 2013;11(1):190. (IF 3.459) 5. Ge N, Lin HX (Co-first authors), Xiao XS, Guo L, Xu HM, Wang X, Jin T, Cai XY, Liang Y, Hu WH, Kang TB. Prognostic significance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma. Journal of Translational Medicine. 2010;94 (8):1-7. (IF 3.459)6. Jin T, Lin HX (Co-first authors), Lin H, Guo LB, Ge N, Cai XY, Sun R, Chen WK, Li QL, Hu WH. Expression TGM2 and BNIP3 have prognostic significance in laryngeal cancer patients receiving surgery and postoperative radiotherapy: a retrospective study. Journal of Translational Medicine. 2012;10(1):64. doi: 10.1186/1479-5876-10-64. (IF 3.459)7. Lin H, Lin HX (Co-first authors), Cai XY, Guo LB, Wang HZ, Ting J, Hu WH. Chemotherapy plus radiotherapy makes curability a possibility for NPC patients with distant metastases at diagnosis. Head and Neck Oncol. 2013;5(1):1 (IF 3.14)8. Lin H, Lin HX (Co-first authors), Ge N, Wang HZ, Sun R, Hu WH. Plasma uric acid and tumor volume are highly predictive of outcome in nasopharyngeal carcinoma patients receiving intensity modulated radiotherapy. Radiat Oncology. 2013;8(1):121. (IF 2.107)9. Lin HX(First author), Yu HM, Liang WP. Investigation and analysis of sharp instrument injuries from 2005 to 2009. Chinese Journal of Nosocomiology. 2010;20(17):2612-2613. (IF 1.402, ranking 8) (200 points)10. Liu JY, Li YH, Lin HX (Co-first authors), Liao YJ, Mai SJ, Liu ZW, Zhang ZL, Jiang LJ, Zhang JX, Kung HF, Zeng YX, Zhou FJ, Xie D. Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder. BMC Cancer. 2013;13:349. (IF 3.333)11. Lin HX(First author), Hua YJ, Chen QY, Luo DH, Sun R, Qiu F, Mo HY, Mai HQ, Guo X, Xian LJ, Hong MH, Guo L. Randomized study of sinusoidal chronomodulated versus flat intermittent induction chemotherapy with cisplatin and 5-fluorouracil followed by traditional radiotherapy in locoregionally advanced nasopharyngeal carcinoma. Chin J Cancer. 2013;32(9):502-11. (IF 0.800)12. Guo L, Lin HX(Corresponding author), Xu M, Chen QY, Wang CT, Huang PY. Phase I study of TPF neoadjuvant chemotherapy followed by radical radiotherapy in advanced nasopharyngeal carcinoma. Chinese Journal of Cancer. 2010;29(2):142-147. 13. Lin HX(First author), Sun R, Xu M, Liao JH, Guo L. Clinical study of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy and concurrent cisplatin in local advanced nasopharyngeal carcinoma. Cancer Research and Clinic. 2010;22(8):515-518.14. Guo L, Lin HX(Corresponding author), Qiu F, Luo DH, Sun R, Guo X, Hong MH. Clinical experience in treating elderly patients with advanced nasopharyngeal carcinoma by using Capecitabine Tablets plus Paraplatin combined with concurrent chemoradiotherapy. Cancer Research on Prevention and Treatment. 2006;5(33):368-370. 15. Xu M, Guo L, Liao JH, Sun R, Lin HX(Corresponding author). Retrospective analysis of efficacy on radiotherapy alone and concurrent chemoradiotherapy for patients with stage T3N0-1M0 nasopharyngeal cancer. Cancer Research and Clinic. 2010;22(8):526-529.16. Yu HM, Lin HX(Corresponding author), Zheng DM, Luo GY. Pre-endoscopy investigation and analysis of the blood borne diseases of tumor patients. Journal of Sun Yat-sen University (Medical Sciences). 2009;30(4S):108-109. Monographs:1. ‘Nasopharynx and Neck Anatomy’, ‘Nasopharyngeal Carcinoma Imaging’, in Diagnosis and Treatment of Nasopharyngeal Carcinoma, edited by Guo L, Lin HX. Guangzhou: World Publishing Guangdong Corporation. 2012, 11;Edition 1. 2. ‘Breast Cancer’, in Practical Clinical Radiation Oncology, edited by Cui NJ, Lu TX, Deng XW. Guangzhou: Sun Yat-sen University Press. 2005, 12. 3. ‘Radiotherapy for Breast Cancer’, in Handbook of Common Malignant Tumor Radiotherapy, edited by Liu MZ. Beijing: Peking University Medical Press. 2010, 1.4. Translator of Handbook of Cancer Prevention, mainly translated by Zhang XP. Beijing: People’s Medical Publishing House. 2011, 7; Edition 1.

Updated by International Office, Sun Yat-sen University Cancer Center